Farxiga Approved to Reduce Risk for CKD Progression
SGLT2 inhibitor approved for patients with CKD to prevent kidney function decline, kidney failure, CV death, hospitalization for heart failure
FDA Approves Higher-Dose Naloxone Hydrochloride Nasal Spray
8-mg dose of naloxone hydrochloride nasal spray now approved with 2-mg and 4-mg doses
Effect of COVID-19 on Breast Cancer Treatment Examined
More patients with estrogen receptor-positive, HER2-negative breast cancer treated with neoadjuvant endocrine therapy due to COVID-19
Anxiety-Related Adverse Event Clusters ID’d After Janssen Vaccine
Rate of syncope was 8.2 per 100,000 doses after Janssen COVID-19 vaccination versus 0.05 per 100,000 after flu shots
Physician’s Briefing Weekly Coronavirus Roundup
Consumers Warned About Bed Rails That Pose Entrapment, Asphyxia Risk
Some models can allow a person to get trapped between the bed rail and mattress or within portions of the rail itself
Fertility Concerns Impact Treatment Decisions in Breast Cancer
One-third of young women with breast cancer indicated that fertility concerns affected decisions relating to endocrine therapy
Side Effects of BNT162b2, ChAdOx1 nCoV-19 Vaccines Quantified
Systemic side effects for 13.5 and 22.0 percent after first, second dose of BNT162b2; 33.7 percent after first dose of ChAdOx1 nCoV-19
Bimekizumab Tops Secukinumab for Plaque Psoriasis
In second study, bimekizumab showed noninferiority and superiority to adalimumab for moderate-to-severe disease
Millions of Americans Have Missed Their Second COVID-19 Vaccine Dose: CDC
Local health authorities struggling to make sure that those who get their first shot also get their second
